Aug 10, 2022 / 08:30PM GMT
Operator
Good afternoon, and welcome to the Spero Therapeutics Second Quarter 2022 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded. and a replay will be available. You can find information on the replay and further information related to today's announcements on the Spero Therapeutics' website at www.sperotherapeutics.com.
At this time, I would like to turn the call over to Ted Jenkins, Vice President, Investor Relations and Strategic Finance at Spero Therapeutics. Mr. Jenkins, please go ahead.
Ted Jenkins - Spero Therapeutics, Inc. - VP & Head of IR
Thank you, operator, and thank you all for participating in today's conference call. This afternoon, Spero Therapeutics released financial results and provided a pipeline update for the second quarter of 2022. Our press release is available on the Investor page of the Spero Therapeutics website.
Before we begin, I'd like to remind you that some of the information
Q2 2022 Spero Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
